1/6
08:21 am
imvt
Rating for IMVT
Low
Report
Rating for IMVT
1/6
08:21 am
imvt
Rating for IMVT
Low
Report
Rating for IMVT
1/6
08:02 am
imvt
Immunovant (NASDAQ:IMVT) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating.
Medium
Report
Immunovant (NASDAQ:IMVT) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating.
1/6
08:02 am
imvt
Immunovant (NASDAQ:IMVT) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating.
Medium
Report
Immunovant (NASDAQ:IMVT) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating.
1/6
07:44 am
imvt
Immunovant upgraded to Outperform from Peer Perform at Wolfe Research
Low
Report
Immunovant upgraded to Outperform from Peer Perform at Wolfe Research
1/6
07:44 am
imvt
Immunovant upgraded to Outperform from Peer Perform at Wolfe Research
Low
Report
Immunovant upgraded to Outperform from Peer Perform at Wolfe Research
12/18
09:09 am
imvt
Immunovant (NASDAQ:IMVT) had its "buy" rating reaffirmed by analysts at Guggenheim.
Medium
Report
Immunovant (NASDAQ:IMVT) had its "buy" rating reaffirmed by analysts at Guggenheim.
12/18
09:09 am
imvt
Immunovant (NASDAQ:IMVT) had its "buy" rating reaffirmed by analysts at Guggenheim.
Medium
Report
Immunovant (NASDAQ:IMVT) had its "buy" rating reaffirmed by analysts at Guggenheim.
12/15
12:47 pm
imvt
Rating for IMVT
Low
Report
Rating for IMVT
12/15
12:47 pm
imvt
Rating for IMVT
Low
Report
Rating for IMVT
12/15
12:47 pm
imvt
Rating for IMVT
Low
Report
Rating for IMVT